Patients were stratified according to prescription of GLP-1 receptor agonists, specifically liraglutide or semaglutide, versus other weight-loss drugs such as lorcaserin, sibutramine, setmelanotide, fenfluramine, mazindol, orlistat, phentermine, and diethylpropion
These are essential to validate biological activity in a more physiological context, evaluating complex cellular processes and possible toxicity, which brings the results closer to in vivo reality
Medication is a powerful component, but it's just one part of the comprehensive support system people need for this transformative health journey
Most of the reported side effects are related to gastrointestinal problems such as nausea, vomiting, diarrhea, stomach paralysis, and constipation